NCT04476823

European Pathology Laboratories and COVID-19

Practice in Clinical and Molecular Thoracic European Pathology Laboratories During the COVID-19 Pandemic.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 71 (actual)
• Sponsor: Centre Hospitalier Universitaire de Nice · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), notably when handling human samples, remains poorly understood, as well as the impact of the COVID-19 pandemic in routine clinical and molecular pathology practice, and for personal working in pathology laboratories. This study evaluates the consequences of the COVID-19 crisis in clinical and molecular pathology laboratories in Europe mostly those orientated for diagnosis of thoracic diseases.

Conditions

• Clinical Practice During the COVID-19 Crisis

Interventions

Type	Name	Description
OTHER	Activity	The questionnaire had requested information on the biosafety organization, impact of the COVID-19 crisis on the clinical and molecular pathology and the biobanking activity in thoracic pathology, on the research activity associated with the COVID-19, and on the educational and training organization. It requested the different needs planned by the different laboratories following the COVID-19 crisis and finally the consequence of this latter on the health and virological status of the staff members.

Timeline

• Start date: 2020-03-15
• Primary completion: 2020-05-31
• Completion: 2020-05-31
• First posted: 2020-07-20
• Last updated: 2020-07-20

Locations

1 site across 1 country: France